Enovate Medical is categorized under Steel-Structural Manufacturers in Murfreesboro, TN and active since 2013.
Enovate Medical was established in 2013, and today employs 1 to 4, earning $20.000.000 to $49.9999.999 per year. This is a Steel-Structural Manufacturers business, which does work in the B2B market, and is classified as a Steel-Structural Manufacturers, under code number 332312 by the NAICS.
If you are seeking more information, feel free to contact Nick Mendez at the company’s headquarters by writing to 1152 Park Avenue, Murfreesboro, Tennessee TN 37129 or by phoning (615) 896-1652. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Enovate Medical |
| Contact Person: | Nick Mendez |
| Address: | 1152 Park Avenue, Murfreesboro, Tennessee 37129 |
| Phone Number: | (615) 896-1652 |
| Website Address: | enovatemedical.com |
| Annual Revenue (USD): | $20.000.000 to $49.9999.999 |
| Founded: | 2013 |
| Location Type: | Headquarters |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Steel-Structural Manufacturers |
| SIC Code: | 3441 |
| NAICS Code: | 332312 |
| Share This Business: |
Enovate Medical was started in 2013 to provide professional Steel-Structural Manufacturers under the SIC code 3441 and NAICS code 332312. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $20.000.000 to $49.9999.999 per annum.
Feel free to contact Nick Mendez for inquiries that concern Enovate Medical by calling the company number (615) 896-1652, as your correspondence is most welcome. Additionally, the physical location of the headquarters of Enovate Medical can be found at the coordinates 35.832532,-86.397619 as well as the street address 1152 Park Avenue in Murfreesboro, Tennessee 37129.
For its online presence, you may visit Enovate Medical’s website at enovatemedical.com and engage with its social media outlets through on Twitter and on Facebook.